Recordati Industria Chimica e Farmaceutica (RCDTF) Earnings Date, Estimates & Call Transcripts → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free RCDTF Stock Alerts $51.60 0.00 (0.00%) (As of 05/7/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRCDTF Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RCDTF Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> Recordati Industria Chimica e Farmaceutica Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$2.81 EPSNext Year EPS Consensus Estimate: $3.04 EPS Recordati Industria Chimica e Farmaceutica Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript11/7/2023Q3 2023-$0.62+$0.62$0.84-$557.14 million7/28/2023Q2 2023-$0.69+$0.69$0.84-$536.58 million5/11/2023Q1 2023-$0.81+$0.81$0.98-$591.52 million3/16/2023Q4 2022-$0.58+$0.58$0.81-$485.80 million11/8/2022Q3 2022-$0.63+$0.63$0.83-$488.89 million7/28/2022Q2 2022-$0.56+$0.56$0.84-$504.07 million Get the Latest News and Ratings for RCDTF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and its competitors with MarketBeat's FREE daily newsletter. 5/10/2022Q1 2022-$0.64+$0.64$0.75-$470.63 million3/17/2022Q4 2021-$0.62+$0.62$0.74-$484.79 million10/28/2021Q3 2021-$0.59+$0.59$0.67-$454.41 million7/29/2021Q2 2021-$0.60+$0.60$0.53-$465.09 million Recordati Industria Chimica e Farmaceutica Earnings - Frequently Asked Questions How much revenue does Recordati Industria Chimica e Farmaceutica generate each year? Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) has a recorded annual revenue of $1.95 billion. How much profit does Recordati Industria Chimica e Farmaceutica generate each year? Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) has a recorded net income of $329.08 million. RCDTF has generated $1.93 earnings per share over the last four quarters. What is Recordati Industria Chimica e Farmaceutica's price-to-earnings ratio? Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) has a trailing price-to-earnings ratio of 26.74 and a forward price-to-earnings ratio of 18.36. What is Recordati Industria Chimica e Farmaceutica's EPS forecast for next year? Recordati Industria Chimica e Farmaceutica's earnings are expected to grow from $2.81 per share to $3.04 per share in the next year, which is a 8.19% increase. More Earnings Resources from MarketBeat Related Companies: SSMXY Earnings AMFPF Earnings SGIOY Earnings ZLDPF Earnings ORINY Earnings GNNDY Earnings CTLT Earnings EXAS Earnings UHS Earnings QGEN Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (OTCMKTS:RCDTF) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recordati Industria Chimica e Farmaceutica S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.